Belotecan, a new camptothecin analogue, was found to be "active and promising" in SCLC patients

Author：

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1628, 2008-01, pp. : 7-7

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

An Overview on the Development of New Potentially Active Camptothecin Analogs Against Cancer

Mini Reviews in Medicinal Chemistry, Vol. 14, Iss. 12, 2014-10 ,pp. : 953-962

Bentham Science Publishers

Access to resources Recommend Favorite

Namitecan: a Hydrophilic Camptothecin with a Promising Preclinical Profile

Current Medicinal Chemistry, Vol. 19, Iss. 21, 2012-07 ,pp. : 3488-3501

Bentham Science Publishers

Access to resources Recommend Favorite

New Perspectives in the Analysis of Ecdysteroids: A Promising Group of Biologically Active Compounds

Current Pharmaceutical Analysis, Vol. 4, Iss. 3, 2008-01 ,pp. : 162-175

Bentham Science Publishers

Access to resources Recommend Favorite

Delivery Methods of Camptothecin and Its Hydrosoluble Analogue Irinotecan for Treatment of Colorectal Cancer

Current Drug Delivery, Vol. 9, Iss. 2, 2012-03 ,pp. : 122-131

Bentham Science Publishers

Access to resources Recommend Favorite

Synthesis and Pharmacology of New Camptothecin Drugs

Mini Reviews in Medicinal Chemistry, Vol. 5, Iss. 5, 2005-05 ,pp. : 425-439

Bentham Science Publishers

Access to resources Recommend Favorite